tucatinib with capecitabine and trastuzumab in advanced her2-positive breast cancer
Published 2 years ago • 65 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
7:38
tucatinib plus trastuzumab & capecitabine for patients with her2-positive breast cancer & brain mets
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
5:50
her2climb: investigating tucatinib with capecitabine and trastuzumab in her2-positive metastatic...
-
2:01
her2climb: tucatinib in combination w/ capecitabine & trastuzumab
-
1:51
tucatinib combination improved survival in her2–positive breast cancer
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
-
1:23
ont-380 in combination with capecitabine and trastuzumab in her2-positive breast cancer
-
4:30
tucatinib for the treatment of her2 breast cancer
-
5:33
capecitabine plus either neratinib or lapatinib for patients with her2 breast cancer
-
2:21
tucatinib with t-dm1 for her2-positive metastatic breast cancer
-
1:23
tucatinib and trastuzumab in the treatment paradigm of her2-positive mcrc
-
3:15
her2climb-02: tucatinib tdm-1 in advanced breast cancer
-
1:11
32 month follow-up of mountaineer: tucatinib and trastuzumab in her2 mcrc
-
1:46
choosing between tucatinib and t-dxd in her2 breast cancer
-
1:12
her2climb-04: tucatinib trastuzumab deruxtecan in her2 breast cancer
-
30:10
2022 ku post san antonio review | metastatic her2 positive breast cancer: novel treatment approaches
-
5:08
new quality-of-life data for tucatinib in her2 breast cancer
-
1:14
updated analysis from mountaineer: tucatinib and trastuzumab for her2-positive mcrc
-
4:58
tucatinib and hrqol among patients with her2 metastatic breast cancer